All filters
Videos
What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials? - A. Gehring, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
New Data From Combination Trials for Chronic Hepatitis B - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Epidemiology of HIV and viral hepatitis in European countries- Marharyta Shylava
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Treatment issues --- Hepatitis-HIV co-infection- Zahedul Islam
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Management of COVID-19- Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Acute hepatitis- Lali Sharvadze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
HIV & COVID-19 Coinfection- Prof. Anca Streinu-Cercel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Liver Disease and COVID-19 Coinfection- Prof. Cihan Yurdaydin
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
SARS-COV-2 Vaccines: a Critical Review- Dr. Kathryn Stephenson
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Update on COVID - 19 Therapeutics- Dr. Daniel Kuritzkes
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
HIV Prevention in High Risk Populations: Unique Challenges and Solutions- Dr. Jean-Michel Molina
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Long-Acting Therapy for PrEP: How Will We Use it?- Mr. Luis Mendão
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Update on Guidelines for Preventing MTCT of Hep B- Dr. Philippa Easterbrook
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Update on the Use of Generic Drugs for HIV in Europe- Ms. Liudmyla Maistat
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Implementation of Integrase Inhibitors for First Line Therapy in the CEE Region: How Far Are We?- Prof. Milosz Parczewski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
EASL Guidelines on Viral Hepatitis Elimination- Prof. Mojca Matičič
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic)- Prof. Nicole Seguy
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
A Phase 3, Open-label, Dose Escalation study to determine the pharmacokinetics of Atazanavir administered with RIfampicin to HIV positive adults on sEcond-line ART regimen with suppressed HIV-1 viral load (DERIVE): Scheduled Interim Analysis
Presenter: Sandra Grañana Castillo
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Videos
Drug-Drug Interactions in Hospitalized COVID-19 Patients Receiving Investigational Drugs (CATCO-DDI)
Presenter: Nancy Sheehan
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020